New Clinical Data Point to Use of GlycoMark as Biomarker of SGLT-2 Diabetes Drug Effectiveness and Compliance

Precision Diabetes, Inc. North Carolina

View original content:https://www.prnewswire.co.uk/news-releases/new-clinical-data-point-to-use-of-glycomark-as-biomarker-of-sglt-2-diabetes-drug-effectiveness-and-compliance-301970323.html